ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,097.60
1.40%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,253.14
1.74%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Galectin Therapeutics Inc (GALT)

  7. Galectin Therapeutics Inc (GALT) 뉴스

GALT Galectin Therapeutics Inc

3.36
-0.14 (-4.00%)
시간외 거래
최종 업데이트: 05:07:04
15분 지연
기업명 주식 심볼 시장 주식 타입
Galectin Therapeutics Inc GALT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.14 -4.00% 3.36 05:07:04
개장가 저가 고가 종가 전일 종가
3.51 3.23 3.54 3.36 3.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/03/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:15EDGAR2Form 8-K - Current report
08/12/202301:42EDGAR2Form 8-K - Current report
02/12/202306:50EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
02/12/202306:38EDGAR2Form SC 13D/A - General statement of acquisition of..
01/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:21EDGAR2Form 8-K/A - Current report: [Amend]
13/11/202322:45GLOBEUPDATE – Galectin Therapeutics Reports Financial Results for..
13/11/202322:00GLOBEGalectin Therapeutics Reports Financial Results for the..
13/11/202321:55EDGAR2Form 8-K - Current report
13/11/202321:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:00GLOBEGalectin Therapeutics to Share Five Scientific Presentations..
01/11/202305:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202321:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
16/10/202321:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202321:00GLOBEGalectin Therapeutics Announces Nomination of Dr. Benjamin..
06/10/202321:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202321:03EDGAR2Form DEF 14A - Other definitive proxy statements
03/10/202321:00GLOBEGalectin Therapeutics Reports the Positive Outcome of the..
02/10/202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/09/202303:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/09/202321:00GLOBEGalectin Therapeutics to Present Update on its Belapectin..
18/09/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202305:38EDGAR2Form 144 - Report of proposed sale of securities
11/09/202321:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
08/09/202301:00GLOBEGalectin Therapeutics to Present Data on Liver Cirrhosis at..
01/09/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/08/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202321:00GLOBEGalectin Therapeutics Reports Financial Results for the..
14/08/202320:55EDGAR2Form 8-K - Current report
14/08/202320:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202305:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/07/202321:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/07/202320:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
GALT
Galectin Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유